Evidence map›Paper›PMID 40779041›Full record

ReviewAesthetic plastic surgery2025

Exosome-Based Therapies in Dermatology.

Susmita Aryal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Aesthetic plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Plant Exosome Injection: A New Boost for Postlaser Vascular Repair.The Journal of clinical and aesthetic dermatology · 2026
    Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Susmita AryalDepartment of Biomedical Engineering, Yonsei University, Wonju, Gangwon-do, 26493, South Korea. susmitaaryal@yonsei.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Exosome-based therapies are becoming one of the most innovative and potentially effective solutions in the dermatology field for skin health, rejuvenation, and aesthetics. Exosomes are described as small membranous structure like vesicles, which are involved in cell-to-cell communication during normal physiological and pathological conditions. These vesicles are surrounded by a lipid bilayer membrane and are released by nearly all kinds of eukaryotic cells. They are usually sized between 30 and 150 nanometers and are loaded with cell-specific cargoes. Earlier considered to be cellular waste resulting from cell damage, exosomes are now being studied due to their unique characteristics such as small size, stability, biocompatibility, high loading capacity of proteins and nucleic acids, low antigenicity, and ability to penetrate cell membranes. These properties of exosomes have made them ideal for use in a broad range of cellular environment and garner tremendous momentum in therapeutic applications, particularly in regenerative medicine. In dermatology, exosomes hold significant potential as they can transfer biologically active molecules and modulate cellular responses offering therapeutic options for chronic wounds, inflammatory disorders, skin cancers, and cosmetic applications. In this regard, this review will briefly review the biogenesis of exosomes and the utilization of exosomes in aesthetic regenerative medicine.

Indexed as

DermatologyExosomesSkin DiseasesHumansRegenerative MedicineRejuvenationAestheticsDermatologyExosome-based therapiesRegenerative medicineSkin rejuvenation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.